As New Yorkers emerge from the pandemic’s economic morass, New York Lt. Gov. Kathy Hochul acknowledged a tough path ahead, but shared hope for the state’s future at Cornell’s annual town-gown regional meeting.
A Cornell-led collaboration has developed a noninvasive blood test that uses cell-free DNA to gauge the damage that COVID-19 inflicts on cells, tissues and organs, and could help aid in the development of new therapies.
Simulations show the helmet, designed by the Esmaily Lab, prevents 99.6% of virus-containing droplets exhaled by medical patients from reaching the environment.
Researchers at Weill Cornell Medicine and Cornell’s Ithaca campus have developed a new computational method for studying genetic and environmental interactions and how they influence disease risk.
One unsung aspect of Cornell’s success in managing the spread of COVID-19 on campus has been a commitment to analyze and learn, to pivot and adapt. As a result, the university will implement tweaks to its COVID-19 response plan this Spring semester.
Cornell is partnering with New York state and Northwell Health System to develop and train the nation’s first state public health corps, which will support COVID-19 vaccination and improve long-term public health outcomes.
The College Scholar Program in the College of Arts & Sciences allows students to design their own interdisciplinary major, organized around a question or issue of interest, and pursue a course of study that cannot be found in an established major.
The grant from The Andrew W. Mellon Foundation’s Just Futures Initiative will bring together scholars from across the university and beyond to study the links between racism, dispossession and migration.
